1. Home
  2. CRIS vs FGF Comparison

CRIS vs FGF Comparison

Compare CRIS & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • FGF
  • Stock Information
  • Founded
  • CRIS 2000
  • FGF 2012
  • Country
  • CRIS United States
  • FGF United States
  • Employees
  • CRIS N/A
  • FGF N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • FGF Property-Casualty Insurers
  • Sector
  • CRIS Health Care
  • FGF Finance
  • Exchange
  • CRIS Nasdaq
  • FGF Nasdaq
  • Market Cap
  • CRIS 32.8M
  • FGF 29.0M
  • IPO Year
  • CRIS 2000
  • FGF N/A
  • Fundamental
  • Price
  • CRIS $3.22
  • FGF $21.36
  • Analyst Decision
  • CRIS Strong Buy
  • FGF
  • Analyst Count
  • CRIS 3
  • FGF 0
  • Target Price
  • CRIS $23.00
  • FGF N/A
  • AVG Volume (30 Days)
  • CRIS 39.9K
  • FGF 43.9K
  • Earning Date
  • CRIS 02-14-2025
  • FGF 03-13-2025
  • Dividend Yield
  • CRIS N/A
  • FGF N/A
  • EPS Growth
  • CRIS N/A
  • FGF N/A
  • EPS
  • CRIS N/A
  • FGF N/A
  • Revenue
  • CRIS $10,259,000.00
  • FGF $22,351,000.00
  • Revenue This Year
  • CRIS N/A
  • FGF N/A
  • Revenue Next Year
  • CRIS N/A
  • FGF N/A
  • P/E Ratio
  • CRIS N/A
  • FGF N/A
  • Revenue Growth
  • CRIS 0.44
  • FGF N/A
  • 52 Week Low
  • CRIS $2.86
  • FGF $14.21
  • 52 Week High
  • CRIS $17.49
  • FGF $38.50
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 47.34
  • FGF 51.89
  • Support Level
  • CRIS $3.05
  • FGF $20.00
  • Resistance Level
  • CRIS $3.55
  • FGF $23.60
  • Average True Range (ATR)
  • CRIS 0.24
  • FGF 1.36
  • MACD
  • CRIS 0.03
  • FGF 0.21
  • Stochastic Oscillator
  • CRIS 47.53
  • FGF 57.29

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About FGF FG Financial Group Inc. (NV)

Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.

Share on Social Networks: